QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 b-riley-securities-initiates-coverage-on-veru-with-buy-rating-announces-price-target-of-5

B. Riley Securities analyst William Woods initiates coverage on Veru (NASDAQ:VERU) with a Buy rating and announces Price Tar...

 hc-wainwright--co-reiterates-buy-on-veru-maintains-3-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Veru (NASDAQ:VERU) with a Buy and maintains $3 price target.

 veru-q2-2024-adj-eps-007-misses-005-estimate-sales-410m-beat-300m-estimate

Veru (NASDAQ:VERU) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 ...

 hc-wainwright--co-maintains-buy-on-veru-raises-price-target-to-3

HC Wainwright & Co. analyst Yi Chen maintains Veru (NASDAQ:VERU) with a Buy and raises the price target from $2 to $3.

 veru-to-present-at-the-glp-1-based-therapeutics-summit

Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserv...

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

 cisco-to-rally-around-24-here-are-10-top-analyst-forecasts-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 oppenheimer-reiterates-outperform-on-veru-lowers-price-target-to-5

Oppenheimer analyst Leland Gershell reiterates Veru (NASDAQ:VERU) with a Outperform and lowers the price target from $7 to $5.

 why-jpmorgan-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

 raymond-james-initiates-coverage-on-veru-with-outperform-rating-announces-price-target-of-3

Raymond James analyst Gary Nachman initiates coverage on Veru (NASDAQ:VERU) with a Outperform rating and announces Price Tar...

 hc-wainwright--co-reiterates-buy-on-veru-maintains-2-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Veru (NASDAQ:VERU) with a Buy and maintains $2 price target.

 veru-q1-sales-210m-miss-520m-estimate

Veru (NASDAQ:VERU) reported quarterly sales of $2.10 million which missed the analyst consensus estimate of $5.20 million by 59...